Practical Aspects of the Use of Topiramate in Patients with Epilepsy
- 1 January 1997
- Vol. 38 (s1) , S56-S58
- https://doi.org/10.1111/j.1528-1157.1997.tb04521.x
Abstract
Practical recommendations for the treatment of patients with the new antiepileptic drug (AED) topiramate (TPM) were developed on the basis of review of the results of controlled and open studies of TPM reported to date and on postmarketing clinical experience with TPM at two specialized epilepsy clinics in the United Kingdom. Recommendations considered important for optimal utilization of TPM include dosage titration guidelines, options for managing side effects occurring early in treatment, advice concerning the withdrawal of concomitant AEDs, indications for discontinuation of TPM, and recognition of the need for adequate patient counseling.Keywords
This publication has 8 references indexed in Scilit:
- Drug Interaction Profile of TopiramateEpilepsia, 1996
- Safety of Topiramate: Adverse Events and Relationships to DosingEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- Intractable Epilepsy in ChildrenEpilepsia, 1996
- Epileptic Spasms in Older Children: Persistence Beyond InfancyEpilepsia, 1995